BackViridian Therapeutics Overview

Viridian Therapeutics Profit Margin

Profitability ratio analysis for VRDN.

Quarterly Profit Margin

-74397.87%
↑ 38.37% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-508.46%
↑ 99.50% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin